PHAIM PHARMA LTDActive

Company number 09355572Private limited companyIncorporated 2014

Key figures

−£911,096-15.2%
Net assets 2024/25
-1 m-500 k0500 k2020/212021/222022/232023/242024/25

Like most small UK companies, PHAIM PHARMA LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Profit for the year-452,569————
Cash at bank and in hand493,10448,042119898
Total assets571,538260,829141,86269,47118,490
Total liabilities114,149663,193918,557860,518929,587
Net assets / total equity457,389-402,364-776,695-791,047-911,096
Average number of employees66650

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

Research and experimental development on biotechnology

As described in the company's latest filed accounts.

Summary: PHAIM PHARMA LTD

Company

PHAIM PHARMA LTD is a private limited company registered with Companies House under company number 09355572. It was incorporated on 15 Dec 2014. Its status is active. The registered office is in London (WC2B). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files small company accounts (filleted). Net assets were −£911,096, down 15.2% on the previous year. Cash at bank and in hand was £98. Total assets were £18,490 and total liabilities £929,587. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

4 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 8 Dec 2026.